CC BY-NC-ND 4.0 · J Lab Physicians 2022; 14(04): 377-383
DOI: 10.1055/s-0042-1757229
Original Article

Prevalence of Dyslipidemia among School-Age Children and Adolescents in Addis Ababa, Ethiopia

Ousman Mohammed
1   Department of Medical Laboratory Sciences, College of Health Sciences, Wollo University, Dessie, Ethiopia
Melkitu Kassaw
2   Food Science and Nutrition Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia
Letebrhan G/Egzeabher
3   Department of Medical Laboratory Sciences, Yekatit 12 General Hospital, Addis Ababa, Ethiopia
Endalkachew Fekadu
4   Department of Medical Laboratory Sciences, Sent Emanuel Specialized Hospital, Addis Ababa, Ethiopia
Demiraw Bikila
5   Department of National Clinical Chemistry Reference Laboratory, Ethiopian Public Health institute, Addis Ababa, Ethiopia
Tigist Getahun
5   Department of National Clinical Chemistry Reference Laboratory, Ethiopian Public Health institute, Addis Ababa, Ethiopia
Feyissa Challa
5   Department of National Clinical Chemistry Reference Laboratory, Ethiopian Public Health institute, Addis Ababa, Ethiopia
Ahmedmenewer Abdu
6   Department of Medical Laboratory Sciences, College of Health Sciences, Haramaya University, Harar, Ethiopia
Kassu Desta
7   Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
Mistire Wolde
7   Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
Aster Tsegaye
7   Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
› Author Affiliations
Funding This research was supported by the Ethiopian Public Health Institute and Ministry of Innovation and Technology. However, they have no role in manuscript writing, editing, approval, or decision to publish.


Objective Lipid abnormalities during childhood might be associated with a higher risk of atherosclerosis development in adulthood. In Ethiopia, there were no data on this area. The present work was aimed at assessing the lipid profile abnormalities among children and adolescents aged between 5 and 17 years, in Addis Ababa, Ethiopia.

Materials and Methods The present school-based cross-sectional study was done from March 2019 to October 2019 in the capital city, Addis Ababa. A total of 504 students were randomly recruited for this study. The total cholesterol, triglyceride, low-density lipoprotein, and high-density lipoprotein-cholesterol levels were determined using the Cobas c501 automated chemistry analyzer. The prevalence of lipid abnormalities was described in percentages. Bivariate and multivariate analyses were performed, and data with p-value less than 0.05 was considered statistically significant.

Results Dyslipidemia in at least one of the lipid profiles was observed in 322 (63.9%) school children, whereas only one of the participants had an abnormality in all four lipid profile tests. The prevalence of total cholesterol 200 mg/dL or higher, low-density lipoprotein 130 mg/dL or higher, high-density lipoprotein less than 40 mg/dL, and triglycerides 130 mg/dL or higher was in 14 (2.8%), 16 (3.2%), 294 (58.4%), and 46 (19.1%) participants, respectively.

Conclusion In the current work, the majority of the study participants had a normal lipid profile except increased prevalence of a reduced concentration of high-density lipoprotein-cholesterol. The overall prevalence of serum lipid abnormalities was 63.9%. Serum lipid levels did not show significant differences with sex, age, fasting habits, or obesity.

Data Availability

Additional data will be available from the corresponding author upon reasonable request.

Declaration of Interest

None declared.

Publication History

Article published online:
20 October 2022

© 2022. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 Yusuf S, Hawken S, Ounpuu S. et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364 (9438): 937-952
  • 2 Anderson TJ, Grégoire J, Hegele RA. et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2013; 29 (02) 151-167
  • 3 Jellinger PS, Smith DA, Mehta AE. et al; AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis. American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract 2012; 18 (Suppl 1): 1-78
  • 4 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285 (19) 2486-2497
  • 5 Newman III WP, Freedman DS, Voors AW. et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 1986; 314 (03) 138-144
  • 6 Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA 1990; 264 (23) 3018-3024
  • 7 Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128 (Suppl 5): S213-S256
  • 8 Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 2003; 107 (11) 1562-1566
  • 9 Kavey RE. Combined dyslipidemia in childhood. J Clin Lipidol 2015; 9 (5, Suppl): S41-S56
  • 10 Garcés C, Gil A, Benavente M, Viturro E, Cano B, de Oya M. Consistently high plasma high-density lipoprotein-cholesterol levels in children in Spain, a country with low cardiovascular mortality. Metabolism 2004; 53 (08) 1045-1047
  • 11 Yang S, Hwang JS, Park HK. et al. Serum lipid concentrations, prevalence of dyslipidemia, and percentage eligible for pharmacological treatment of Korean children and adolescents; data from the Korea National Health and Nutrition Examination Survey IV (2007-2009). PLoS One 2012; 7 (12) e49253
  • 12 Taheri F, Kazemi T, Bijari B, Namakin K, Zardast M, Chahkandi T. Prevalence of dyslipidemia among elementary school children in Birjand, East of Iran, 2012. J Tehran Heart Cent 2016; 11 (01) 15-20
  • 13 Faria Neto JR, Bento VF, Baena CP. et al. ERICA: prevalence of dyslipidemia in Brazilian adolescents. Rev Saude Publica 2016; 50 (Suppl 1): 10s
  • 14 Lartey A, Marquis GS, Aryeetey R, Nti H. Lipid profile and dyslipidemia among school-age children in urban Ghana. BMC Public Health 2018; 18 (01) 320
  • 15 Rerksuppaphol S, Rerksuppaphol L. Prevalence of dyslipidemia in Thai schoolchildren. J Med Assoc Thai 2011; 94 (06) 710-715
  • 16 de Alcântara Neto OD, Silva RdeC, Assis AM, Pinto EdeJ. Factors associated with dyslipidemia in children and adolescents enrolled in public schools of Salvador, Bahia. Rev Bras Epidemiol 2012; 15 (02) 335-345
  • 17 Dathan-Stumpf A, Vogel M, Hiemisch A. et al. Pediatric reference data of serum lipids and prevalence of dyslipidemia: Results from a population-based cohort in Germany. Clin Biochem 2016; 49 (10–11): 740-749
  • 18 Hirschler V, Maccallini G, Aranda C, Molinari C. San Antonio de los Cobres Study Group. Dyslipidemia without obesity in indigenous Argentinean children living at high altitude. J Pediatr 2012; 161 (04) 646.e1-651.e1
  • 19 Al-Shehri SN, Saleh ZA, Salama MM, Hassan YM. Prevalence of hyperlipidemia among Saudi school children in Riyadh. Ann Saudi Med 2004; 24 (01) 6-8
  • 20 Villarreal E, Forero Y, Poveda E, Baracaldo C, López E. Cardiovascular risk markers in schoolchildren from five provinces of eastern Colombia [in Spanish]. Biomedica 2008; 28 (01) 38-49
  • 21 Guerrero-Romero F, Rodríguez-Morán M. Prevalence of dyslipidemia in non-obese prepubertal children and its association with family history of diabetes, high blood pressure, and obesity. Arch Med Res 2006; 37 (08) 1015-1021
  • 22 Daniels SR. Lipid concentrations in children and adolescents: it is not all about obesity. Am J Clin Nutr 2011; 94 (03) 699-700